SymbioPharm

SymbioPharm GmbH has been a pioneer in microbiome research and knowledge-based probiotics since 1954. Its mission is to harness the pure biological effects of natural bacteria to maintain health and treat diseases with probiotics. Therefore, it studies the human microbiome and develops innovative microbial therapies. The company possesses state-of-the-art production facilities and, together with the Institute for Microecology, demonstrates comprehensive expertise ranging from diagnostics to innovative solutions.